Executive dysfunction and long-term outcomes of geriatric depression
- PMID: 10711915
- DOI: 10.1001/archpsyc.57.3.285
Executive dysfunction and long-term outcomes of geriatric depression
Abstract
Background: This study investigated the relationship of executive and memory impairment to relapse, recurrence, and course of residual depressive symptoms and signs after remission of geriatric major depression.
Methods: Fifty-eight elderly subjects remitted from major depression received continuation nortriptyline treatment (plasma levels 60-150 ng/mL) for 16 weeks and then were randomly assigned to either nortriptyline maintenance therapy or placebo for up to 2 years. Diagnosis was made using the Research Diagnostic Criteria and the DSM-IV criteria after an interview using the Schedule for Affective Disorders and Schizophrenia. Executive dysfunction and memory were assessed with the Dementia Rating Scale, disability and social support were rated with the Philadelphia Multiphasic Instrument, and medical burden was assessed with the Cumulative Illness Rating Scale.
Results: Abnormal initiation and perseveration scores, but not memory impairment, were associated with relapse and recurrence of geriatric depression and with fluctuations of depressive symptoms in the whole group and in subjects who never met criteria for relapse or recurrence during the follow-up period. Memory impairment, disability, medical burden, social support, and history of previous episodes did not significantly influence the outcome of depression in this sample.
Conclusions: Executive dysfunction was found to be associated with relapse and recurrence of geriatric major depression and with residual depressive symptoms. These observations, if confirmed, will aid clinicians in identifying patients in need of vigilant follow-up. The findings of this study provide the rationale for investigation of the role of specific prefrontal pathways in predisposing or perpetuating depressive syndromes or symptoms in elderly patients.
Similar articles
-
Executive dysfunction, heart disease burden, and remission of geriatric depression.Neuropsychopharmacology. 2004 Dec;29(12):2278-84. doi: 10.1038/sj.npp.1300557. Neuropsychopharmacology. 2004. PMID: 15340393
-
[Depression and frontal dysfunction: risks for the elderly?].Encephale. 2009 Sep;35(4):361-9. doi: 10.1016/j.encep.2008.03.012. Epub 2008 Oct 1. Encephale. 2009. PMID: 19748373 French.
-
Executive dysfunction and the course of geriatric depression.Biol Psychiatry. 2005 Aug 1;58(3):204-10. doi: 10.1016/j.biopsych.2005.04.024. Biol Psychiatry. 2005. PMID: 16018984 Clinical Trial.
-
[Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].Encephale. 2001 Sep-Oct;27(5):405-15. Encephale. 2001. PMID: 11760690 Review. French.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
Cited by
-
Structural and functional differences in the brains of patients with MCI with and without depressive symptoms and their relations with Alzheimer's disease: an MRI study.Psychoradiology. 2023 Jun 13;3:kkad008. doi: 10.1093/psyrad/kkad008. eCollection 2023. Psychoradiology. 2023. PMID: 38666129 Free PMC article.
-
Assessing depression recurrence, cognitive burden, and neurobiological homeostasis in late life: Design and rationale of the REMBRANDT Study.J Mood Anxiety Disord. 2024 Mar;5:100038. doi: 10.1016/j.xjmad.2023.100038. Epub 2023 Nov 4. J Mood Anxiety Disord. 2024. PMID: 38523701 Free PMC article.
-
Hearing loss and risk of depressive symptoms in older adults in the Health ABC study.Front Epidemiol. 2022 Oct 5;2:980476. doi: 10.3389/fepid.2022.980476. eCollection 2022. Front Epidemiol. 2022. PMID: 38455326 Free PMC article.
-
Biological factors influencing depression in later life: role of aging processes and treatment implications.Transl Psychiatry. 2023 May 10;13(1):160. doi: 10.1038/s41398-023-02464-9. Transl Psychiatry. 2023. PMID: 37160884 Free PMC article. Review.
-
Leukoaraiosis as a Predictor of Depression and Cognitive Impairment among Stroke Survivors: A Systematic Review.Neurol Int. 2023 Feb 13;15(1):238-272. doi: 10.3390/neurolint15010016. Neurol Int. 2023. PMID: 36810471 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
